Genentech’s Spinal Muscular Atrophy Therapy Shows Significant Improvement in Motor Function Risdiplam showed medically-meaningful and statistically significant results patients with type 2 and type 3 SMA. 0 MIN READ 02.6.2020
Orchard Therapeutics’ $200 Million IPO Expected This Week for Gene Therapy Programs Autologous gene therapy for rare diseases including primary immune deficiencies, inherited metabolic disorders and blood disorders (Image: Orchard Therapeutics). 4 MIN READ 10.30.2018
PTC Therapeutics Acquiring Agilis and Gene Therapy Portfolio for $200 Million Deal includes $745 million in potential additional milestone payments based on success of Agilis' central nervous system therapies. 3 MIN READ 07.20.2018
Here’s a Catalayst Play In PTC Therapeutics, Inc. (NASDAQ:PTCT) Here's a look at an upcoming catalyst for PTC therapeutics. 3 MIN READ 09.22.2017
Investment Opportunities in Emerging Therapeutic Industries Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of 18 MIN READ 07.30.2014
